Font Size: a A A
Keyword [hepatitis B patients]
Result: 161 - 180 | Page: 9 of 10
161. Analysis Of Baseline Predictors Of E Antigen Seroconversion In HBeAg-positive Chronic Hepatitis B Patients With Telbivudine Treatment
162. The Clinical Significance Of Detection The Interleukin-18and NO Change In The Serum Of Chronic Severe Hepatitis B Patients And The Relevant Studies With Entecavir Treatment
163. Tolerability And Early Efficacy Of Albumin Interferon-α2a In Chronic Hepatitis B Patients
164. The Clinical Curative Effect Observation Of PEG-IFNa-2a And Entecavir In The Treatment Of Chronic Hepatitis B Patients With Positive HBeAg
165. An Alteration In The Expression Fcγ Receptor In Immune Status Of HBV Infected
166. The Research Of Intestinal Microbiota In Chronic Hepatitis B Patients
167. The Effect Of Peripheral Blood TGF-Beta On Hbeag Serological Conversion Of Chronic Hepatitis B Patients Treated With Nucleoside Analogues
168. The Efficacy Of Adefovir Dipivoxil Add-on Therapy In HBeAg Positive Chronic Hepatitis B Patients With Poor Virological Response To Peg-IFN-α
169. Efficacy Of Peg-interferon Alpha-2a Combinated With Entecavir On HBeAg Positive Chronic Hepatitis B Patients
170. Analysis Of Hepatitis B Virus Resistance Genemutations In Chronic Hepatitis B Patients On Drug Combination
171. Dynamic Changes And Clinical Significance Of IL-27 In Serums Of Chronical Viral Hepatitis B Patients
172. Clinical Significance Of T Cell Immunoglobulin And Mucin-3 In Chronic Hepatitis B Patients
173. The Change Of Serum HBsAg And HBeAg Levels In Chronic Hepatitis B Patients During Antiviral Therapy And Their Role In Predicting Response
174. Efficacy And Predictive Markers Of Stepwise Optimization Strategy In HbeAg Positive Chronic Hepatitis B Patients Treated With PegIFN α-2a
175. Study For Predicting Hepatitis B E Antigen Seroconversion To Interferon-α In Chronic Hepatitis B Patients
176. The Viral And Immune Genetics Study Of Hbe Ag/HBeAb Seroconversion In Chonic Hepatitis B Patients
177. Analytical Investigation Of Changes Of Th17/Treg Balance And Level Of Specific Transcription Factor(RORγt、Foxp3) In Chronic Hepatitis B Patients
178. A New Model Combining The Liver/spleen Volume Ratio And Classification Of Varices Predicts HVPG In Hepatitis B Patients With Cirrhosis
179. Risk Assessment Of Hepatocellular Carcinoma In Chronic Hepatitis B Patients By Transient Elastography
180. The Kinetics Of HBsAg During Long Term Nucleos(t)Ide Analogue Treatment In Chronic Hepatitis B Patients
  <<First  <Prev  Next>  Last>>  Jump to